Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 157

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 157
---
 the structure of the
Change of Control) obligations, duties and covenants under this Agreement. No later than five (5) Business Days after the consummation of any Change of Control or other transaction, Purchaser will deliver to the Rights Agent an Officer’s
Certificate, stating that such Change of Control or other transaction complies with this Section 4.6(i) and that all conditions precedent herein relating to such transaction have been complied with.

AMENDMENTS

Without the consent of any Holders, the Representative, Purchaser and the Rights Agent, at any
time and from time to time, may enter into one or more amendments hereto, for any of the following purposes:

to evidence the succession
of another Person to Purchaser and the assumption by any such successor of the covenants of Purchaser herein as provided in ; that, in each case, such provisions do not adversely affect the interests of the
Holders;

to add to the covenants of Purchaser such further covenants, restrictions, conditions or provisions as the Representative,
Purchaser and the Rights Agent will consider to be for the protection of the Holders;

to cure any ambiguity, to correct or supplement
any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with respect to matters or questions arising under this Agreement; provided that, in each case, such provisions do not
adversely affect the interests of the Holders;

as may be necessary or appropriate to ensure that the CVRs are not subject to
registration under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, and to ensure that the CVRs are not subject to any similar registration or
prospectus requirement under applicable securities laws outside of the United States; that, in each case, such provisions do not adversely affect the interests of the Holders;

to evidence the succession of another Person as a successor Rights Agent or the Representative and the assumption by any such successor of
the covenants and obligations of the Rights Agent or the Representative, as applicable, herein in accordance with and ; or

any other amendments hereto for the purpose of adding, eliminating or changing any provisions of this Agreement; that, in
each case, such addition, elimination or change does not adversely affect the interests of the Holders in any material respect.

Without
the consent of any Holders, the Representative